Oryzon Genomics S.A. (ORY.MC)
EUR 1.59
(-3.98%)
EUR 1.59
(-3.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 14.19 Million | - | - | - | - |
| Cost of Revenue | 243.69 Thousand | -15.23 Million | -9.86 Million | -8.99 Million | - |
| Gross Profit | 13.94 Million | 15.23 Million | 9.86 Million | 8.99 Million | - |
| Operating Expenses | 18.49 Million | 20.72 Million | 16.87 Million | 13.28 Million | 10.54 Million |
| Selling, General and Administrative Expenses | 3.6 Million | 17.61 Million | 13.06 Million | 9.67 Million | 10.55 Million |
| Research and Development Expenses | 6.23 Million | - | - | - | - |
| Other Expenses | 8.65 Million | - | - | - | -7500.00 |
| Cost and Expenses | 4.54 Million | 5.48 Million | 7 Million | 4.28 Million | 10.54 Million |
| Operating Income | -4.54 Million | -5.48 Million | -7.01 Million | -4.29 Million | -10.54 Million |
| Interest Expense | 1.89 Million | 1.11 Million | 455.57 Thousand | 469.08 Thousand | - |
| Income Tax Expense | -2.75 Million | -2.32 Million | -2.49 Million | -1.37 Million | - |
| Earnings before Tax | -6.1 Million | -6.55 Million | -7.17 Million | -4.77 Million | - |
| Net Income | -3.35 Million | -4.23 Million | -4.68 Million | -3.39 Million | - |
| Earnings Per Share Basic | -0.06 | -0.08 | -0.09 | -0.06 | - |
| Earnings Per Share Diluted | -0.06 | -0.08 | -0.09 | -0.06 | - |
| Weighted Average Shares Outstanding | 60.87 Million | 56.04 Million | 52.76 Million | 52.76 Million | 52.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.87 Million | 56.04 Million | 52.76 Million | 52.76 Million | 52.76 Million |
| Gross Margin | 0.98 | - | - | - | - |
| EBIT Margin | -0.31 | - | - | - | - |
| Profit Margin | -0.24 | - | - | - | - |
| EBITDA | -4.43 Million | -5.35 Million | -6.88 Million | -4.16 Million | -3.69 Million |
| Earnings Before Tax Margin | -0.32 | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 4.1 Million | - | - | - | - |
| Cost of Revenue | - | 170.47 Thousand | - | -3.18 Million | -13.94 Million | -3.41 Million |
| Gross Profit | - | 3.93 Million | - | 3.18 Million | 13.94 Million | 3.41 Million |
| Operating Expenses | 2.79 Million | 3.1 Million | 3.24 Million | 4.48 Million | 18.49 Million | 4.18 Million |
| Selling, General and Administrative Expenses | 879 Thousand | 296.3 Thousand | 799.14 Thousand | - | - | - |
| Research and Development Expenses | 1.91 Million | 647.98 Thousand | 2.44 Million | - | - | - |
| Other Expenses | - | 1.46 Million | 2.22 Million | - | - | - |
| Cost and Expenses | 2.79 Million | -835.74 Thousand | 3.24 Million | 1.29 Million | 4.54 Million | 779.26 Thousand |
| Operating Income | -2.79 Million | 835.74 Thousand | -3.24 Million | -1.29 Million | -4.54 Million | -779.26 Thousand |
| Interest Expense | - | - | - | 573.35 Thousand | 1.89 Million | 264.25 Thousand |
| Income Tax Expense | - | -2 Million | 129.64 Thousand | -16.36 Thousand | -2.75 Million | -30.61 Thousand |
| Earnings before Tax | -1.37 Million | -1.9 Million | -1.01 Million | -1.73 Million | -6.1 Million | -1.09 Million |
| Net Income | -1.37 Million | 107.17 Thousand | -1.14 Million | -1.72 Million | -3.35 Million | -1.06 Million |
| Earnings Per Share Basic | -0.02 | 0.00 | -0.02 | -0.03 | - | -0.02 |
| Earnings Per Share Diluted | -0.02 | 0.00 | -0.02 | -0.03 | - | -0.02 |
| Weighted Average Shares Outstanding | 63.38 Million | 61.21 Million | 61.21 Million | 58.45 Million | 60.87 Million | 58.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.38 Million | 61.21 Million | 61.21 Million | 58.45 Million | 60.87 Million | 58.15 Million |
| Gross Margin | - | 0.96 | - | - | - | - |
| EBIT Margin | - | 0.21 | - | - | - | - |
| Profit Margin | - | 0.03 | - | - | - | - |
| EBITDA | -2.79 Million | 850.47 Thousand | -3.24 Million | -1.17 Million | - | -793.23 Thousand |
| Earnings Before Tax Margin | - | 0.20 | - | - | - | - |
ENNPF
OLE
FPRUY
ENDGF
LRGR
STLTECH